91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Global BCG Vaccination Market Growth 2025-2031

Global BCG Vaccination Market Growth 2025-2031

Publication ID: 
LPI03257391
Publication Date: 
March 4, 2025
Pages: 
111
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

The global BCG Vaccination market size is predicted to grow from US$ 80.7 million in 2025 to US$ 97 million in 2031; it is expected to grow at a CAGR of 3.1% from 2025 to 2031.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
The “BCG Vaccination Industry Forecast” looks at past sales and reviews total world BCG Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected BCG Vaccination sales for 2025 through 2031. With BCG Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccination industry.
This Insight Report provides a comprehensive analysis of the global BCG Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BCG Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccination.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Immune Vaccine
Therapy Vaccine
Segmentation by Application:
Self-Procurement
UNICEF
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Key Questions Addressed in this Report
What is the 10-year outlook for the global BCG Vaccination market?
What factors are driving BCG Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccination market opportunities vary by end market size?
How does BCG Vaccination break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global BCG Vaccination Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for BCG Vaccination by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for BCG Vaccination by Country/Region, 2020, 2024 & 2031
2.2 BCG Vaccination Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 BCG Vaccination Sales by Type
2.3.1 Global BCG Vaccination Sales Market Share by Type (2020-2025)
2.3.2 Global BCG Vaccination Revenue and Market Share by Type (2020-2025)
2.3.3 Global BCG Vaccination Sale Price by Type (2020-2025)
2.4 BCG Vaccination Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 BCG Vaccination Sales by Application
2.5.1 Global BCG Vaccination Sale Market Share by Application (2020-2025)
2.5.2 Global BCG Vaccination Revenue and Market Share by Application (2020-2025)
2.5.3 Global BCG Vaccination Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global BCG Vaccination Breakdown Data by Company
3.1.1 Global BCG Vaccination Annual Sales by Company (2020-2025)
3.1.2 Global BCG Vaccination Sales Market Share by Company (2020-2025)
3.2 Global BCG Vaccination Annual Revenue by Company (2020-2025)
3.2.1 Global BCG Vaccination Revenue by Company (2020-2025)
3.2.2 Global BCG Vaccination Revenue Market Share by Company (2020-2025)
3.3 Global BCG Vaccination Sale Price by Company
3.4 Key Manufacturers BCG Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccination Product Location Distribution
3.4.2 Players BCG Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for BCG Vaccination by Geographic Region
4.1 World Historic BCG Vaccination Market Size by Geographic Region (2020-2025)
4.1.1 Global BCG Vaccination Annual Sales by Geographic Region (2020-2025)
4.1.2 Global BCG Vaccination Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic BCG Vaccination Market Size by Country/Region (2020-2025)
4.2.1 Global BCG Vaccination Annual Sales by Country/Region (2020-2025)
4.2.2 Global BCG Vaccination Annual Revenue by Country/Region (2020-2025)
4.3 Americas BCG Vaccination Sales Growth
4.4 APAC BCG Vaccination Sales Growth
4.5 Europe BCG Vaccination Sales Growth
4.6 Middle East & Africa BCG Vaccination Sales Growth
5 Americas
5.1 Americas BCG Vaccination Sales by Country
5.1.1 Americas BCG Vaccination Sales by Country (2020-2025)
5.1.2 Americas BCG Vaccination Revenue by Country (2020-2025)
5.2 Americas BCG Vaccination Sales by Type (2020-2025)
5.3 Americas BCG Vaccination Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccination Sales by Region
6.1.1 APAC BCG Vaccination Sales by Region (2020-2025)
6.1.2 APAC BCG Vaccination Revenue by Region (2020-2025)
6.2 APAC BCG Vaccination Sales by Type (2020-2025)
6.3 APAC BCG Vaccination Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe BCG Vaccination by Country
7.1.1 Europe BCG Vaccination Sales by Country (2020-2025)
7.1.2 Europe BCG Vaccination Revenue by Country (2020-2025)
7.2 Europe BCG Vaccination Sales by Type (2020-2025)
7.3 Europe BCG Vaccination Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa BCG Vaccination by Country
8.1.1 Middle East & Africa BCG Vaccination Sales by Country (2020-2025)
8.1.2 Middle East & Africa BCG Vaccination Revenue by Country (2020-2025)
8.2 Middle East & Africa BCG Vaccination Sales by Type (2020-2025)
8.3 Middle East & Africa BCG Vaccination Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccination
10.3 Manufacturing Process Analysis of BCG Vaccination
10.4 Industry Chain Structure of BCG Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccination Distributors
11.3 BCG Vaccination Customer
12 World Forecast Review for BCG Vaccination by Geographic Region
12.1 Global BCG Vaccination Market Size Forecast by Region
12.1.1 Global BCG Vaccination Forecast by Region (2026-2031)
12.1.2 Global BCG Vaccination Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global BCG Vaccination Forecast by Type (2026-2031)
12.7 Global BCG Vaccination Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccination Product Portfolios and Specifications
13.1.3 Merck BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab BCG Vaccination Product Portfolios and Specifications
13.2.3 Japan BCG Lab BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India BCG Vaccination Product Portfolios and Specifications
13.3.3 Serum Institute of India BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines BCG Vaccination Product Portfolios and Specifications
13.4.3 AJ Vaccines BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma BCG Vaccination Product Portfolios and Specifications
13.5.3 BioFarma BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma BCG Vaccination Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec BCG Vaccination Product Portfolios and Specifications
13.7.3 China National Biotec BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin BCG Vaccination Product Portfolios and Specifications
13.8.3 Biomed Lublin BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals BCG Vaccination Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva BCG Vaccination Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC – Institute of Vaccines and Medical Biologicals
13.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
13.11.2 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccination Product Portfolios and Specifications
13.11.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IVAC – Institute of Vaccines and Medical Biologicals Main Business Overview
13.11.5 IVAC – Institute of Vaccines and Medical Biologicals Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst BCG Vaccination Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen BCG Vaccination Product Portfolios and Specifications
13.13.3 Microgen BCG Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-bcg-vaccination-market-growth-2025-2031

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare